{
  "meta": {
    "title": "Motor_Neuron_Disease_Ms_Other_Demyelinating_Disorders",
    "url": "https://brainandscalpel.vercel.app/motor-neuron-disease-ms-other-demyelinating-disorders-b4853da4.html",
    "scrapedAt": "2025-11-30T11:13:13.115Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Guillain-Barr&eacute; Syndrome</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Motor neuron disease</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Inflammatory Demyelinating Polyneuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old man develops swallowing difficulties and complains of difficulty walking up stairs. On examination, there is weakness and wasting of the distal muscles of the arms. There are visible fasciculations. Reflexes are brisk, and the plantar reflexes are upgoing. There are no sensory abnormalities. Speech and language assessment suggests the presence of pharyngeal muscle weakness. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1186407",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186407,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient exhibits a combination of upper and lower motor neuron signs, without any sensory involvement, which strongly suggests <strong>motor neuron disease (MND)</strong>.</li>\r\n<li><strong>UMN features</strong>: Brisk reflexes and extensor plantar response (Babinski sign).</li>\r\n<li><strong>LMN features</strong>: Muscle wasting, distal weakness, and visible fasciculations.</li>\r\n<li><strong>Bulbar involvement</strong>: Difficulty in swallowing and speech, suggesting pharyngeal muscle weakness (seen in bulbar or pseudobulbar palsy).</li>\r\n<li>Absence of <strong>sensory involvement</strong> rules out conditions like CIDP and GBS.</li>\r\n<li><strong>A chronic, progressive course</strong> is more characteristic of MND than GBS (which typically presents with an acute onset) or myasthenia (which exhibits fatigability without fasciculations).</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>MND (particularly ALS) shows mixed UMN + LMN signs.</li>\r\n<li>Fasciculations are a hallmark of LMN degeneration.</li>\r\n<li>No sensory symptoms are a classic diagnostic clue.</li>\r\n<li>Dysphagia and dysarthria suggest bulbar involvement, which is common in MND.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Guillain-Barr&eacute; Syndrome (Option A):</strong> Typically, acute onset with symmetrical ascending weakness and sensory involvement; fasciculations and UMN signs are not typical.</p>\r\n<p><strong>Myasthenia gravis (Option C):</strong> Shows fatigable weakness, especially ocular/bulbar muscles; no fasciculations or UMN/LMN signs.</p>\r\n<p><strong>Chronic Inflammatory Demyelinating Polyneuropathy (Option D):</strong> Involves both motor and sensory nerves; reflexes are usually reduced, not brisk.<strong></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>A combination of upper and lower motor neuron signs without sensory involvement is strongly indicative of motor neuron disease, particularly ALS.</li>\r\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Wilson's disease</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Creutzfeldt Jakob disease</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Motor neuron disease</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man presents with weakness in the extensors of the upper limb and the flexors of the lower limb. His speech has a nasal quality. There is tongue fasciculation. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1186416",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186416,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The presence of both upper and lower motor neuron signs, along with a nasal speech quality, points toward <strong>motor neuron disease (MND).</strong></li>\r\n<li><strong>UMN features</strong>: Weakness of upper limb extensors and lower limb flexors is characteristic.</li>\r\n<li><strong>LMN features</strong>: Fasciculations (e.g., tongue fasciculation) and nasal speech due to palatal muscle weakness.</li>\r\n<li>MND can present with a combination of <strong>bulbar, limb, and respiratory muscle involvement</strong>.</li>\r\n<li>Fasciculations are hallmark signs of lower motor neuron degeneration and are <strong>not seen in NMJ disorders</strong> like myasthenia gravis.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>MND typically has no sensory symptoms.</li>\r\n<li>Onset usually occurs in mid to late adulthood, and the disease is progressive.</li>\r\n<li>Speech involvement may be bulbar (LMN) or pseudobulbar (UMN) in nature.</li>\r\n<li>Nasal quality of voice suggests palatal weakness (bulbar involvement).<br /> </li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202404068e34dd3b-1617-4f95-87f5-6ffcdb002d61.png\">\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Wilson's disease (Option A):</strong> Presents with extrapyramidal signs, hepatic dysfunction, and psychiatric symptoms, not pure motor weakness with fasciculations.<strong></strong></p>\r\n<p><strong>Creutzfeldt-Jakob disease (Option B):</strong> Characterised by rapidly progressive dementia, myoclonus, and death, not isolated motor findings.<strong></strong></p>\r\n<p><strong>Myasthenia gravis (Option D):</strong> Causes fatigable weakness, especially ocular and bulbar; fasciculations are not seen.<strong></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>A combination of UMN and LMN signs with bulbar involvement (nasal speech, tongue fasciculations) in the absence of sensory symptoms is classic for motor neuron disease.</li>\r\n</ul>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 3</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 9</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 17</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 19</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old male is accompanied to the office by his wife, who has noticed that his memory is deteriorating. She also reports that at dinner parties, he is inappropriate in his behaviour, and she thinks that his personality has changed. On examination, the patient has frontal lobe release signs. He is hypotonic in the arms, but his reflexes are brisk. He has fasciculations in the tongue and all four limbs. You suspect frontotemporal dementia (FTD) with amyotrophic lateral sclerosis (ALS).<br>On which chromosome is the responsible gene located?</span></p>",
      "unique_key": "DT1186429",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The co-occurrence of frontotemporal dementia (FTD) with ALS is most commonly associated with a mutation in the <strong>C9orf72 gene on chromosome 9</strong>.</li>\r\n<li><strong>FTD-ALS overlap syndrome</strong> often presents with behavioural changes, frontal release signs, and progressive motor dysfunction.</li>\r\n<li>The <strong>C9orf72 mutation</strong> is a hexanucleotide (GGGGCC) repeat expansion in a non-coding region.</li>\r\n<li>It accounts for <strong>45-50%</strong> of familial ALS and a significant portion of behavioural variant FTD with ALS.</li>\r\n<li><strong>Fasciculations</strong> and <strong>brisk reflexes</strong> suggest mixed upper and lower motor neuron signs characteristic of ALS.</li>\r\n<li><strong>Frontal lobe signs</strong> and personality changes support a diagnosis of behavioural variant FTD.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Other genetic mutations linked to familial ALS include <strong>SOD1</strong>, <strong>TDP-43</strong>, and <strong>FUS/TLS</strong>.</li>\r\n<li><strong>Chromosome 17</strong> is linked to other FTD types but not typically associated with ALS co-occurrence.</li>\r\n<li>Behavioural variant FTD is the most common phenotype when ALS overlaps with FTD.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Chromosome 3 (Option A):</strong> Not associated with FTD-ALS spectrum disorders.<strong></strong></p>\r\n<p><strong>Chromosome 17 (Option C):</strong> Associated with tau mutations in pure FTD, not when coexisting with ALS.<strong></strong></p>\r\n<p><strong>Chromosome 19 (Option D):</strong> Commonly associated with the ApoE4 allele in Alzheimer's disease, not ALS-FTD.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Dementia</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysphagia</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Muscle cramps</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic atrophy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following features are not compatible with the diagnosis of motor neurone disease (MND)?</span></p>",
      "unique_key": "DT1186441",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186441,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Optic atrophy is not a recognised feature of motor neuron disease (MND).</strong></li>\r\n<li>MND affects motor neurons, sparing sensory pathways and optic nerves.</li>\r\n<li>Cranial nerves involved in eye movements (III, IV, VI) are preserved until late stages, and the optic nerve (II) is unaffected.</li>\r\n<li>Dementia, particularly behavioural variant frontotemporal dementia, may occur in familial ALS due to C9orf72 mutations.</li>\r\n<li>Dysphagia is a common presentation due to bulbar muscle involvement.</li>\r\n<li>Muscle cramps, especially early morning or post-activity, can occur early in MND and are often distressing to patients.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Sensory impairment</strong>, <strong>optic nerve involvement</strong>, and <strong>bladder/bowel dysfunction</strong> are not typical of MND and suggest alternative diagnoses.</li>\r\n<li>Cognitive involvement (esp. executive dysfunction) is increasingly recognised, particularly in familial ALS.</li>\r\n<li>Eye movements and optic nerve functions are preserved until very advanced stages.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Dementia (Option A):</strong> Behavioural FTD is associated with familial MND.<strong></strong></p>\r\n<p><strong>Dysphagia (Option B):</strong> Common due to bulbar involvement.<strong></strong></p>\r\n<p><strong>Muscle cramps (Option C):</strong> Common symptom in early disease stages.<strong></strong></p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical spondylosis</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Motor neurone disease</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple sclerosis</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Spinal muscular atrophy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 59-year-old woman presents with poly-symptomatology. On examination, she has prominent fasciculations. From which of the following conditions is she unlikely to suffer?</span></p>",
      "unique_key": "DT1186453",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Fasciculations are characteristic of lower motor neuron (LMN) pathology</strong>, which is <strong>not seen in multiple sclerosis (MS).</strong></li>\r\n<li>Fasciculations arise from spontaneous discharges of diseased anterior horn cells or nerve roots.</li>\r\n<li>Cervical spondylosis may cause LMN signs due to nerve root compression, and thus, fasciculations can be seen. <strong>(Option A)</strong></li>\r\n<li>Motor neuron disease (e.g., ALS) is the classic condition showing mixed UMN + LMN signs, including fasciculations. <strong>(Option B)</strong></li>\r\n<li><strong>Spinal muscular atrophy</strong> is an <strong>inherited LMN disorder</strong>, and fasciculations are often prominent. <strong>(Option D)</strong></li>\r\n<li><strong>MS is a central demyelinating disease</strong> affecting white matter tracts; it predominantly causes <strong>UMN symptoms</strong> with <strong>sensory involvement</strong>, and <strong>fasciculations are not a feature</strong>.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Fasciculations are not seen in <strong>neuromuscular junction disorders</strong> or <strong>myopathies</strong>.</li>\r\n<li>In MND, <strong>tongue fasciculations</strong> are a classic finding.</li>\r\n<li><strong>MS involves CNS demyelination</strong>, not the anterior horn cells or peripheral motor neurons.</li>\r\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan of the brain and spine</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI of the brain and spine</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Lumbar Spine X-ray</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">EMG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 39-year-old lady has difficulty walking. On examination, she has an ataxic gait, increased tone in the legs with hyperreflexia and motor weakness. What diagnostic investigation should be arranged?</span></p>",
      "unique_key": "DT1186484",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186484,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient shows signs of both <strong>pyramidal tract involvement</strong> (increased tone, hyperreflexia, weakness) and <strong>ataxia</strong>, which may result from <strong>posterior column</strong> or <strong>cerebellar</strong></li>\r\n<li>These findings raise the possibility of <strong>Multiple Sclerosis</strong> or <strong>subacute combined degeneration</strong> (e.g., B12 deficiency).</li>\r\n<li><strong>MRI is the investigation of choice</strong> for evaluating <strong>demyelinating lesions</strong> in the brainstem, cerebellum, and spinal cord.</li>\r\n<li>MRI provides superior soft-tissue contrast and can detect periventricular plaques, corpus callosum lesions, and spinal cord demyelination, critical for diagnosing MS.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>MS plaques</strong> are best visualised using <strong>T2/FLAIR MRI</strong>.</li>\r\n<li><strong>Spinal cord MRI</strong> is essential for detecting cervical or thoracic lesions in demyelinating diseases.</li>\r\n<li>B12 deficiency can also mimic MS clinically and radiologically; hence, further biochemical tests may be needed in parallel.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>CT scan (Option A):</strong> Limited sensitivity for posterior fossa and spinal cord; may miss demyelinating lesions.<strong></strong></p>\r\n<p><strong>Lumbar spine X-ray (Option C):</strong> Only evaluates bony structures; not useful for evaluating neurological symptoms.<strong></strong></p>\r\n<p><strong>EMG (Option D):</strong> Evaluates muscle or peripheral nerve disorders; not helpful in central demyelination.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic atrophy</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic neuritis</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Papilledema</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic neuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old man has a painful right eye. On examination, there is decreased visual acuity and a relative afferent pupillary defect of the right eye.<br>What is the diagnosis?</span></p>",
      "unique_key": "DT1186489",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186489,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The classical triad of <strong>painful vision loss</strong>, <strong>RAPD</strong>, and <strong>decreased visual acuity</strong> is highly suggestive of <strong>optic neuritis</strong>.</li>\r\n<li><strong>Optic neuritis</strong> is most commonly associated with <strong>demyelinating disorders</strong>, especially <strong>Multiple Sclerosis</strong>.</li>\r\n<li>Pain is typically <strong>retro-orbital</strong> and worsens with eye movements.</li>\r\n<li>A <strong>relative afferent pupillary defect (RAPD)</strong> is a key clinical sign due to impaired conduction in the optic nerve.</li>\r\n<li>It may present as <strong>retrobulbar neuritis</strong> (normal fundus), <strong>optic papillitis</strong> (disc swelling), or <strong>neuroretinitis</strong> (disc + macular star).</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>MRI of the brain and orbits</strong> is used to detect associated demyelinating lesions.</li>\r\n<li>High-dose <strong>steroids</strong> accelerate recovery, though the long-term outcome is unchanged.</li>\r\n<li>Often, the <strong>first manifestation of MS</strong> is in young adults.</li>\r\n<li><strong>Visual recovery</strong> usually begins within 2-3 weeks, even without treatment.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240328ce32e477-689b-42e4-8482-36119a3438ef.jpg\">\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Optic atrophy (Option A):</strong> Result of chronic damage; not painful and no RAPD in early stages.<strong></strong></p>\r\n<p><strong>Papilledema (Option C):</strong> Bilateral disc swelling due to raised ICP; typically painless and without RAPD.<strong></strong></p>\r\n<p><strong>Optic neuropathy (Option D):</strong> General term for optic nerve dysfunction; not specific, and does not imply inflammation.<strong></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Painful vision loss with RAPD in a young adult strongly suggests optic neuritis, often linked to MS.</li>\r\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Left cerebellopontine angle</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Right parietal area</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Right medial longitudinal fasciculus</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Left medial longitudinal fasciculus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 41-year-old man presented with double vision and was found to have normal vertical eye movements. On left lateral gaze, there was an absence of adduction of the right eye, and nystagmus in the abducting left eye. This eye movement disorder can be explained by a lesion in the:</span></p>",
      "unique_key": "DT1186497",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>This patient has <strong>right internuclear ophthalmoplegia (INO)</strong>, which is caused by a lesion in the <strong>right medial longitudinal fasciculus (MLF)</strong>.</li>\r\n<li><strong>INO</strong> results from a lesion in the <strong>MLF</strong>, a tract connecting the contralateral abducens nucleus (VI) to the ipsilateral oculomotor nucleus (III).</li>\r\n<li>On <strong>left lateral gaze</strong>, the <strong>right eye fails to adduct</strong>, and the <strong>left eye shows abducting nystagmus,</strong> a classic feature of INO.</li>\r\n<li><strong>Convergence is typically preserved</strong>, helping distinguish it from a third nerve palsy.</li>\r\n<li>In <strong>young patients</strong>, <strong>multiple sclerosis</strong> is the most common cause; in older adults, vascular disease is more likely.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240328ac6715d0-58a2-4eae-bece-9787962bf99b.jpg\"><br>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240330bd9ae969-6f8b-48f3-a4a1-ebf5a8948d99.jpg\"><p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>INO is a <strong>disconnection syndrome;</strong> the command to move both eyes laterally reaches the abducens nucleus but not the opposite medial rectus.</li>\r\n<li><strong>Horizontal diplopia</strong> occurs due to misalignment.</li>\r\n<li><strong>Unilateral INO</strong> suggests MS in young individuals; <strong>bilateral INO</strong> is highly specific for MS.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403308b3cc438-f14b-4687-8ae0-7cda989d3ba1.jpg\"><p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Left cerebellopontine angle (Option A):</strong> May cause CN VII or VIII palsy, not INO.<strong></strong></p>\r\n<p><strong>Right parietal area (Option B):</strong> Involved in spatial attention; not responsible for eye movement coordination.<strong></strong></p>\r\n<p><strong>Left MLF (Option D):</strong> Would cause left INO, not right-sided adduction deficit.<strong></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Internuclear ophthalmoplegia with impaired adduction of one eye and abducting nystagmus in the other eye indicates a lesion in the ipsilateral medial longitudinal fasciculus.</li>\r\n</ul>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral lymphoma</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple sclerosis</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute demyelinating encephalomyelitis</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Lyme disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old teacher has a right-sided headache and blurring of her vision in the right eye. She had previously had an episode of optic neuritis 3 years beforehand, in the right eye. On examination, there was a right afferent pupillary defect and a pale optic disc. There was weakness of the facial muscles on the right. Tone and reflexes were brisk on the right with power of 3/5 in the arm and the leg. She was afebrile. MRI of the brain reveals a 4 cm left temporo-parietal mass, which was incompletely ring-enhancing. There were also two small white matter lesions visible in the frontal area. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1186501",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>This case is highly suggestive of <strong>multiple sclerosis (MS)</strong> with <strong>relapsing demyelinating episodes</strong> and typical <strong>neuroimaging findings</strong>:</li>\r\n<li>Prior history of <strong>optic neuritis</strong>, now recurrent, with <strong>RAPD</strong> and <strong>optic disc pallor</strong> (suggesting optic atrophy).</li>\r\n<li>The presence of <strong>UMN signs</strong> (hyperreflexia, hemiparesis) supports <strong>CNS demyelination</strong>.</li>\r\n<li>MRI reveals <strong>white matter lesions</strong> and a <strong>4 cm mass with incomplete ring enhancement</strong>, which is a known feature in a rare MS variant called <strong>Balo's concentric sclerosis</strong>.</li>\r\n<li>Balo's sclerosis may mimic a <strong>space-occupying lesion</strong> but typically shows <strong>incomplete or concentric ring enhancement</strong> and occurs in the setting of MS.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>CNS lymphoma</strong> often shows <strong>complete ring enhancement</strong>, is associated with <strong>HIV</strong>, and lacks prior demyelinating episodes.</li>\r\n<li><strong>ADEM</strong> is a <strong>monophasic demyelinating disorder</strong>, often post-infectious, and does not relapse over the years.</li>\r\n<li><strong>Lyme disease</strong> is uncommon and presents with <strong>meningoradiculitis</strong>, not isolated optic neuritis and focal mass lesions.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Cerebral lymphoma (Option A):</strong> Usually presents with <strong>homogeneous or complete ring enhancement</strong>, often in immunocompromised patients.<strong></strong></p>\r\n<p><strong>Acute demyelinating encephalomyelitis (Option C):</strong> Typically <strong>monophasic</strong>, occurs after infection/vaccination, and is not likely to recur years apart.<strong></strong></p>\r\n<p><strong>Lyme disease (Option D):</strong> Presents with neurological signs like <strong>meningitis, radiculopathy</strong>, or <strong>cranial nerve palsies</strong>, but not demyelinating mass lesions.<strong></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Multiple sclerosis can rarely present as a mass-like lesion with incomplete ring enhancement (Balo's variant); recurrence and optic neuritis history further support the diagnosis.</li>\r\n</ul>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Nerve conduction studies</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">CT of the head</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Paired CSF and serum for oligoclonal bands</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum copper and ceruloplasmin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old man has difficulty with his vision. On examination, he has impaired adduction of the right eye looking left. The left eye has jerky nystagmus. Which investigation is most likely to yield a diagnosis?</span></p>",
      "unique_key": "DT1186504",
      "question_audio": null,
      "question_video": null,
      "map_id": 1186504,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient has <strong>internuclear ophthalmoplegia (INO)</strong>, a hallmark eye movement disorder classically seen in <strong>multiple sclerosis (MS)</strong>.</li>\r\n<li>INO is caused by a lesion in the <strong>medial longitudinal fasciculus (MLF)</strong>.</li>\r\n<li>In young adults, <strong>MS is the most common cause</strong>; in older adults, it's often vascular.</li>\r\n<li><strong>CSF analysis for oligoclonal bands</strong> detects intrathecal IgG synthesis, which is present in <strong>~75-85%</strong> of MS cases.</li>\r\n<li>While <strong>MRI is the first-line imaging</strong>, the presence of <strong>oligoclonal bands</strong> in CSF confirms chronic CNS inflammation and supports MS diagnosis.</li>\r\n<li>Paired testing with serum rules out systemic IgG production as the source.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/204032808420e94-a29a-47d7-834b-f094cccf85d3.jpg\">\r\n<p><strong>Internuclear ophthalmoplegia - patient looking to the left</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240328f5d58699-88a0-4d4e-90ae-0559f696dbee.jpg\">\r\n<ul>\r\n<li>MR imaging of the brain showed multiple abnormal high signals on T2WI involving bilateral deep white matter, corpus callosum, occipital periventricular regions, and periaqueductal regions of the pons and medulla.<strong></strong></li>\r\n</ul>\r\n<p><strong>Diagnostic tools in MS:</strong></p>\r\n<p><strong>MRI</strong></p>\r\n<ul>\r\n<li>Magnetic resonance imaging (MRI) of the brain and spine may show areas of demyelination (lesions or plaques).</li>\r\n<li>Gadolinium can be administered intravenously as a contrast agent to highlight active plaques and, by elimination, demonstrate the existence of historical lesions not associated with symptoms at the moment of the evaluation.</li>\r\n<li>Central vein signs (CVS) have been proposed as a good indicator of MS in comparison with other conditions causing white lesions.</li>\r\n<li>Brain atrophy is seen as an indicator of MS.</li>\r\n</ul>\r\n<p><strong>Cerebrospinal fluid</strong></p>\r\n<ul>\r\n<li>Testing of cerebrospinal fluid obtained from a lumbar puncture can provide evidence of chronic inflammation in the central nervous system.</li>\r\n<li>The <strong>cerebrospinal fluid is tested for oligoclonal bands of IgG on electrophoresis</strong>, which are inflammation markers found in 75-85% of people with MS.<strong></strong></li>\r\n</ul>\r\n<p><strong>Evoked potential</strong></p>\r\n<p><strong>Visual- and sensory-evoked potential tests measure brain responses; </strong>the nervous system in MS may respond less actively to stimulation of the optic nerve and sensory nerves due to demyelination of such pathways.</p>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Nerve conduction studies (Option A):</strong> Useful for peripheral neuropathies; not central demyelination.<strong></strong></p>\r\n<p><strong>CT of the head (Option B):</strong> Less sensitive for white matter lesions; may miss demyelination.<strong></strong></p>\r\n<p><strong>Serum copper and ceruloplasmin (Option D):</strong> Used in Wilson's disease; unrelated to INO or MS.</p>\r\n<p><strong></strong></p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic infarct in the occipital lobe on the left side</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Demyelination of the optic nerve of the right eye with multiple demyelinating patches in the brain and the spinal cord</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningeal enhancement diffusely</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Space-occupying lesion in the occipital lobe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old female comes with a 3-month history of multiple neurological symptoms. It started with a blurring of vision in the right eye. She has noted that the visual blurring increases when she takes a hot shower. She also has multiple episodes of an electric shock-like sensation radiating from her spine down to both lower limbs. On examination, she has an afferent pupillary defect in the right eye, with a pale disc. She also has bilateral lower limb spasticity and hyperreflexia, with extensor plantar response. What will be the likely findings in the MRI of the brain and spinal cord in this patient?</span></p>",
      "unique_key": "DT1231857",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231857,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient's symptoms are characteristic of <strong>Multiple Sclerosis (MS)</strong> with <strong>classic clinical and imaging findings</strong>:</li>\r\n<li><strong>Optic neuritis</strong>: Right RAPD and optic atrophy indicate prior inflammation of the optic nerve.</li>\r\n<li><strong>Uhthoff's phenomenon</strong>: Symptom worsening after hot showers is highly suggestive of MS.</li>\r\n<li><strong>Lhermitte's symptom</strong>: Electric shock-like sensation down the spine points to <strong>cervical spinal cord involvement</strong>.</li>\r\n<li><strong>Upper motor neuron signs</strong>: Bilateral lower limb spasticity, hyperreflexia, and extensor plantar response.</li>\r\n<li>MRI is expected to show <strong>T2/FLAIR hyperintense demyelinating plaques</strong> in the <strong>optic nerve</strong>, <strong>periventricular white matter</strong>, <strong>spinal cord</strong>, and <strong>corpus callosum</strong>.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Classic MRI sign: <strong>Dawson's fingers,</strong> T2 hyperintense lesions radiating perpendicular to the ventricles.</li>\r\n<li>90% of plaques in MS are <strong>asymptomatic</strong> but detectable by MRI.</li>\r\n<li><strong>CSF oligoclonal bands</strong> and <strong>evoked potentials</strong> are supportive investigations.</li>\r\n<li>MS has <strong>relapsing-remitting</strong> or <strong>progressive</strong> clinical courses.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Chronic infarct (Option A):</strong> Localised lesion; would not explain bilateral UMN signs or optic neuritis.<strong></strong></p>\r\n<p><strong>Meningeal enhancement (Option C):</strong> Suggests meningitis, not demyelination.<strong></strong></p>\r\n<p><strong>Space-occupying lesion (Option D):</strong> Could cause focal deficits, but not the widespread demyelinating picture.<strong></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Optic neuritis, Uhthoff's and Lhermitte's signs with bilateral UMN symptoms are classic for MS, supported by demyelinating lesions in the brain and spinal cord on MRI.</li>\r\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous Immunoglobulins</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Methyl Prednisolone 1g/day for 3-5 days</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma exchange</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female comes to you with paraplegia of one day duration, with a sensory level at T10; she has bladder involvement and is catheterised. She gives a history of loss of vision in her left eye, one year ago, with residual defective vision. She was not on any follow-up. Her MRI brain and spinal cord shows multiple T2 hyperintense lesions. What will be the treatment of this patient?</span></p>",
      "unique_key": "DT1231858",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231858,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>This patient presents with an <strong>acute demyelinating episode</strong> on the background of suspected <strong>Multiple Sclerosis</strong> (prior optic neuritis, now transverse myelitis), supported by <strong>MRI findings of multiple T2 lesions</strong>.</li>\r\n<li><strong>High-dose IV methylprednisolone (1g/day for 3-5 days)</strong> is the <strong>first-line treatment</strong> for acute MS exacerbations.</li>\r\n<li>It hastens recovery by reducing inflammation and oedema in demyelinated plaques.</li>\r\n<li>A <strong>2-week taper with oral steroids</strong> (e.g., prednisolone 60-80 mg/day) may follow to prevent rebound.</li>\r\n<li><strong>Optic neuritis + transverse myelitis</strong> suggests a relapsing course of MS; long-term disease-modifying therapy may follow after stabilisation.<strong></strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>IVIG</strong> and <strong>Plasma exchange</strong> are <strong>second-line options</strong>, used when there's no response to corticosteroids.</li>\r\n<li><strong>Rituximab</strong> is a disease-modifying therapy considered for <strong>relapsing forms of MS</strong> but not used in acute attacks.</li>\r\n<li>Early aggressive steroid therapy can reduce the extent of disability in severe relapses.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong></strong><strong>Intravenous Immunoglobulins (Option A):</strong> Reserved for specific autoimmune neuromuscular conditions, not first-line for MS.<strong></strong></p>\r\n<p><strong>Plasma exchange (Option C):</strong> Used only if steroid therapy fails.<strong></strong></p>\r\n<p><strong>Rituximab (Option D):</strong> Long-term immunosuppression; not used in acute MS relapses.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Fingolimod</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Dimethyl Fumarate</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Glatiramir acetate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old female comes with sensory symptoms in the form of hypoesthesia beginning from the nipple downwards of subacute onset. She was evaluated, suspecting a demyelination and the diagnosis of Multiple Sclerosis was made with MRI and positive oligoclonal bands. She has no visual symptoms, and her VEP is normal. She does not have any bladder symptoms or motor symptoms. Which of the following is a highly efficacious disease-modifying therapy for her treatment?</span></p>",
      "unique_key": "DT1231859",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231859,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Although this patient has a relatively <strong>mild clinical presentation</strong>, MRI and CSF findings confirm a diagnosis of <strong>relapsing-remitting MS (RRMS)</strong>. According to the current consensus:</li>\r\n<li><strong>Early initiation</strong> of <strong>highly efficacious DMTs</strong> is <strong>preferred</strong> to delay disability progression.</li>\r\n<li><strong>Rituximab</strong>, an <strong>anti-CD20 monoclonal antibody</strong>, is among the most <strong>efficacious therapies</strong> for MS and has shown effectiveness even in <strong>first demyelinating events</strong>.</li>\r\n<li>Anti-CD20 therapies reduce <strong>B-cell-mediated inflammation</strong>, which plays a central role in MS pathogenesis.<strong></strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Other highly efficacious agents include <strong>Ocrelizumab</strong>, <strong>Ofatumumab</strong>, <strong>Alemtuzumab</strong>, and <strong>Natalizumab</strong>.</li>\r\n<li><strong>Moderately effective DMTs</strong>: Fingolimod, Dimethyl fumarate, Cladribine.</li>\r\n<li><strong>Modest efficacy DMTs</strong>: Interferons, Glatiramer acetate, Teriflunomide.</li>\r\n<li><strong>Siponimod</strong> is preferred for <strong>secondary progressive.</strong><strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Fingolimod (Option B):</strong> Moderately efficacious; oral agent, preferred in mild disease or patients desiring convenience.<strong></strong></p>\r\n<p><strong>Dimethyl fumarate (Option C):</strong> Moderately effective; used in less severe or stable disease.<strong></strong></p>\r\n<p><strong>Glatiramer acetate (Option D):</strong> Low efficacy injectable therapy; not preferred in initial high-risk MS cases.</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple Sclerosis</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">NMO Spectral disorders</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">MOG antibody-associated disease</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">ADEM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female presents with an acute onset of weakness of both lower limbs with urinary retention. She has decreased sensations below the nipple. She has a history of recurrent optic neuritis without papilledema in the past. An MRI of the spine was taken, which showed demyelination extending from D5 to D9 segments of the spinal cord. What is the diagnosis?</span></p>",
      "unique_key": "DT1231860",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231860,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>This patient presents with <strong>longitudinally extensive transverse myelitis (LETM)</strong>, defined as a spinal cord lesion extending <strong>&ge;3 vertebral segments</strong>.</li>\r\n<li>LETM is <strong>characteristic of Neuromyelitis Optica Spectrum Disorders (NMOSD)</strong>.</li>\r\n<li>NMOSD is associated with <strong>anti-aquaporin-4 antibodies</strong>, often involves <strong>recurrent optic neuritis</strong>, and typically <strong>lacks disc swelling (no papilledema)</strong>.</li>\r\n<li>The combination of <strong>optic neuritis + LETM</strong> is diagnostic of NMOSD, not MS or MOG-associated disease.</li>\r\n<li>In <strong>Multiple Sclerosis</strong>, spinal cord lesions are typically <strong>short-segment (&lt;2 vertebral segments)</strong>.</li>\r\n<li>In <strong>MOG-associated disease</strong>, papillitis is common, and the cord involvement may be long or short.</li>\r\n<li><strong>ADEM</strong> is a <strong>monophasic illness</strong>, often post-infectious or post-vaccinal, and would not present with recurrent episodes.<strong></strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Optic neuritis in NMOSD</strong> tends to be <strong>more severe</strong> and <strong>bilateral</strong> than in MS.</li>\r\n<li><strong>Anti-AQP4 antibody testing</strong> confirms the diagnosis.</li>\r\n<li><strong>NMOSD treatment</strong> includes steroids for acute attacks and <strong>immunosuppressants</strong> (e.g., Rituximab) for long-term control.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Multiple Sclerosis (Option A):</strong> Typically has short-segment spinal cord lesions and milder optic neuritis.<strong></strong></p>\r\n<p><strong>MOG antibody disease (Option C):</strong> Often shows <strong>papillitis</strong> with optic neuritis; not seen here.<strong></strong></p>\r\n<p><strong>ADEM (Option D):</strong> Monophasic and post-infectious; not associated with recurrent optic neuritis.<strong></strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Longitudinal spinal cord demyelination with recurrent optic neuritis strongly suggests NMO spectrum disorder.</li>\r\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Adalimumab</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Ocrelizumab</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Eculizumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs are approved for the treatment of NMO to prevent relapse?</span></p>",
      "unique_key": "DT1231862",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231862,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation for answer:</strong></p>\r\n<ul>\r\n<li><strong>Eculizumab</strong> is a <strong>monoclonal antibody against the complement protein C5</strong> and is <strong>FDA-approved</strong> for the prevention of relapses in <strong>AQP4 antibody-positive NMO spectrum disorder</strong>.</li>\r\n<li>It blocks the formation of the <strong>membrane attack complex</strong>, thereby reducing CNS damage mediated by complement activation.</li>\r\n<li>It is used in patients with <strong>confirmed AQP4-IgG positivity</strong> and a relapsing course of NMOSD.</li>\r\n<li>While <strong>Rituximab</strong> (anti-CD20) is used <strong>off-label</strong> with good efficacy, only <strong>Eculizumab, Satralizumab, and Inebilizumab</strong> have <strong>specific approval</strong> for NMO relapse prevention.<strong></strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Satralizumab</strong>: Anti-IL-6 receptor monoclonal antibody.</li>\r\n<li><strong>Inebilizumab</strong>: Anti-CD19 monoclonal antibody.</li>\r\n<li><strong>Rituximab</strong>: Off-label but commonly used; targets CD20 on B cells.</li>\r\n<li><strong>Adalimumab</strong>: TNF-alpha inhibitor; used in autoimmune diseases like RA, not NMO.</li>\r\n<li><strong>Ocrelizumab</strong>: Approved for <strong>multiple sclerosis</strong>, not NMO.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>Rituximab (Option A):</strong> Effective in NMO but not FDA-approved specifically for relapse prevention.<strong></strong></p>\r\n<p><strong>Adalimumab (Option B):</strong> Not used in NMO; it's for rheumatoid arthritis and Crohn's disease.<strong></strong></p>\r\n<p><strong>Ocrelizumab (Option C):</strong> Approved for MS, not for NMO.</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">CAG trinucleotide repeats</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">CGG trinucleotide repeats</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">GAA trinucleotide repeats</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">CTG trinucleotide repeats</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old male presents with a history of weakness of both lower limbs of insidious onset for the past 2 years. He has mild difficulty in swallowing liquids as well. There are no sensory symptoms. On examination, he has fasciculations and areflexia. You also notice gynecomastia. He is also undergoing evaluation for infertility. What is the likely molecular abnormality seen in this patient?</span></p>",
      "unique_key": "DT1231911",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231911,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The presentation is classical for <strong>Spinobulbar muscular atrophy (Kennedy's disease),</strong> a rare <strong>X-linked recessive motor neuron disease</strong>.</li>\r\n<li>The patient exhibits pure lower motor neuron (LMN) signs: fasciculations, areflexia, and no sensory loss.</li>\r\n<li>Associated endocrine signs: gynecomastia, infertility, indicating androgen receptor dysfunction.</li>\r\n<li><strong>Kennedy's disease</strong> is caused by CAG trinucleotide repeat expansion in the androgen receptor (AR) gene on the X chromosome.</li>\r\n<li>CAG repeats lead to toxic gain-of-function in the receptor, impairing neuromuscular and endocrine function.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Weakness typically begins in the <strong>proximal lower limbs</strong>, followed by bulbar involvement (e.g., dysphagia).</li>\r\n<li><strong>Gynecomastia and testicular atrophy</strong> are due to androgen resistance.</li>\r\n<li>Unlike ALS, Kennedy's disease has <strong>no UMN signs</strong> and <strong>slow progression</strong>.<strong></strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong><strong></strong></p>\r\n<p><strong>CGG trinucleotide repeats (Option B):</strong> Seen in <strong>Fragile X syndrome</strong>, associated with mental retardation and ataxia.<strong></strong></p>\r\n<p><strong>GAA trinucleotide repeats (Option C):</strong> Found in <strong>Friedreich's ataxia</strong>, which presents with cerebellar and sensory ataxia.<strong></strong></p>\r\n<p><strong>CTG trinucleotide repeats (Option D):</strong> Cause <strong>myotonic dystrophy</strong>, with distal weakness, myotonia, and multisystem involvement.</p>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}